ES526738A0 - Procedimiento para la preparacion de derivados de benzodioxino pirrol. - Google Patents

Procedimiento para la preparacion de derivados de benzodioxino pirrol.

Info

Publication number
ES526738A0
ES526738A0 ES526738A ES526738A ES526738A0 ES 526738 A0 ES526738 A0 ES 526738A0 ES 526738 A ES526738 A ES 526738A ES 526738 A ES526738 A ES 526738A ES 526738 A0 ES526738 A0 ES 526738A0
Authority
ES
Spain
Prior art keywords
benzodioxin
procedure
preparation
pirrol
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES526738A
Other languages
English (en)
Spanish (es)
Other versions
ES8504200A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES8504200A1 publication Critical patent/ES8504200A1/es
Publication of ES526738A0 publication Critical patent/ES526738A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES526738A 1982-10-25 1983-10-25 Procedimiento para la preparacion de derivados de benzodioxino pirrol. Granted ES526738A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8230379 1982-10-25

Publications (2)

Publication Number Publication Date
ES8504200A1 ES8504200A1 (es) 1985-04-16
ES526738A0 true ES526738A0 (es) 1985-04-16

Family

ID=10533819

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526738A Granted ES526738A0 (es) 1982-10-25 1983-10-25 Procedimiento para la preparacion de derivados de benzodioxino pirrol.

Country Status (18)

Country Link
US (1) US4496579A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5998086A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR840006486A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2055283A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE898072A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH661046A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3338753A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES526738A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI833887A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2534921B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2129795B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR79405B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL70034A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1212893B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU85059A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8303673A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE8305866L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA837921B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8410459D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Chemical compounds
DE3579189D1 (de) * 1984-04-24 1990-09-20 Glaxo Group Ltd Heterocyclische aminoverbindungen.
GB8526210D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical compounds
US4769367A (en) * 1984-04-24 1988-09-06 Glaxo Group Limited Heterocyclic amino compounds
GB8526209D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical process
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8828032D0 (en) * 1988-12-01 1989-01-05 Glaxo Group Ltd Medicaments
DE10107243A1 (de) * 2001-02-16 2002-08-22 Bayer Ag Benzodioxinopyrrole, deren Herstellung und Verwendung
US8099200B2 (en) 2005-09-30 2012-01-17 Coombs Joshua D Vehicle interface based on the weight distribution of a user
US20070074922A1 (en) * 2005-09-30 2007-04-05 Coombs Joshua D Vehicle interface based on a shift of the torso of a user
US20070074921A1 (en) * 2005-09-30 2007-04-05 Coombs Joshua D Vehicle interface based on a shift of the appendages of a user
US20090076686A1 (en) * 2005-09-30 2009-03-19 Jeffrey Schox Vehicle interface to communicate a safety alert mode command
US20070078569A1 (en) * 2005-09-30 2007-04-05 Jeffrey Schox Vehicle interface to communicate a safety alert mode command

Also Published As

Publication number Publication date
FI833887A7 (fi) 1984-04-26
FR2534921A1 (fr) 1984-04-27
SE8305866D0 (sv) 1983-10-25
CH661046A5 (fr) 1987-06-30
IT1212893B (it) 1989-11-30
JPS5998086A (ja) 1984-06-06
ES8504200A1 (es) 1985-04-16
BE898072A (fr) 1984-04-25
FR2534921B1 (fr) 1987-01-16
GB2129795B (en) 1986-02-12
IL70034A0 (en) 1984-01-31
LU85059A1 (fr) 1985-06-19
GR79405B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-10-22
KR840006486A (ko) 1984-11-30
ZA837921B (en) 1985-04-24
NL8303673A (nl) 1984-05-16
SE8305866L (sv) 1984-04-26
AU2055283A (en) 1984-05-03
IT8349214A0 (it) 1983-10-25
FI833887A0 (fi) 1983-10-25
GB2129795A (en) 1984-05-23
GB8328468D0 (en) 1983-11-23
US4496579A (en) 1985-01-29
DE3338753A1 (de) 1984-04-26

Similar Documents

Publication Publication Date Title
ES520089A0 (es) Procedimiento para la fabricacion de nuevos derivados arilicos de la piperacina.
ES504791A0 (es) Procedimiento para la preparacion de derivados de caprolactama.
ES524997A0 (es) Procedimiento para la preparacion de derivados de la desoxiuridina
ES526738A0 (es) Procedimiento para la preparacion de derivados de benzodioxino pirrol.
ES538464A0 (es) Procedimiento para la preparacion de derivados de acilamida.
ES520579A0 (es) Procedimiento para la preparacion de eteres oximicos.
ES520812A0 (es) Procedimiento para la preparacion de 3-azolil-1,2-diaril-1-halogeno-1-propenos.
ES522786A0 (es) Procedimiento para preparar derivados de piperacina.
ES546506A0 (es) Procedimiento para la preparacion de nuevos derivados de 3-fenil-4-cianopirrol.
ES502212A0 (es) Procedimiento para la preparacion de n-di-n-propil-2,6-dini-tro-4-trifluorometilanilina
AR240460A1 (es) Procedimeitno para la preparacion de derivados de antraciclina.
ES519529A0 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas.
ES518274A0 (es) Procedimiento para la preparacion de derivados de tiazolina.
ES520537A0 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES520706A0 (es) Procedimiento para la preparacion de sulfonilureas.
ES521979A0 (es) Procedimiento para la preparacion de disulfuros.
ES521331A0 (es) Procedimiento para la preparacion de n-pteridinilureas.
ES519085A0 (es) Procedimiento para la preparacion de compuestos de benzotiazol.
ES534338A0 (es) Procedimiento para la preparacion de derivados de acridanona
ES525034A0 (es) Procedimiento para la preparacion de derivados de 28-metil-brassinolidas
ES520986A0 (es) Procedimiento para la preparacion de derivados de 2-piridona.
ES522859A0 (es) Procedimiento para la obtencion de derivados de trifluormetilfenoxi-fenilo.
ES517348A0 (es) Procedimiento para la preparacion de n-acetil-tiazolidin-4-carboxilato de hexametilentetramina.
ES507234A0 (es) Procedimiento para la preparacion de derivados de bis-amino-metil-antraquinona.
ES520278A0 (es) Procedimiento para la preparacion de derivados bencileterados de pentita.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991108